- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.09. | Treace Medical präsentiert 5-Jahres-Studienergebnisse zur Hallux-valgus-Chirurgie | 1 | Investing.com Deutsch | ||
| 17.09. | Treace Medical presents 5-year bunion surgery study results | 1 | Investing.com | ||
| 17.09. | Treace Medical Concepts, Inc.: Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty Procedure | 139 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 15.09. | Treace Medical Concepts, Inc.: Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting | 5 | GlobeNewswire (USA) | ||
| 07.08. | Earnings Call: Treace Medical übertrifft Q2-Prognosen - Aktie springt um 24 % | - | Investing.com Deutsch | ||
| 07.08. | Treace Medical Concepts GAAP EPS of -$0.24 beats by $0.06, revenue of $45.4M beats by $1.48M | 2 | Seeking Alpha | ||
| TREACE MEDICAL CONCEPTS Aktie jetzt für 0€ handeln | |||||
| 07.08. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.08. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Second Quarter 2026 Financial Results | 461 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 07.08. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 24.07. | Treace Medical Concepts, Inc.: Treace to Report Second Quarter 2026 Financial Results on August 7, 2026 | 2 | GlobeNewswire (USA) | ||
| 18.06. | Treace Medical Concepts, Inc.: Treace Announces First Surgical Case with the HyperPlate XM Dynamic Compression Locking Implant System | 2 | GlobeNewswire (USA) | ||
| 20.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 08.05. | Treace Medical: Aktie steigt nach übertroffenen Quartalszahlen trotz Umsatzminus | 1 | Investing.com Deutsch | ||
| 08.05. | Treace Medical Concepts GAAP EPS of -$0.28 beats by $0.03, revenue of $47.2M beats by $1.15M | 3 | Seeking Alpha | ||
| 08.05. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports First Quarter 2026 Financial Results | 854 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.04. | Treace Medical Concepts, Inc.: Treace to Report First Quarter 2026 Financial Results on May 8, 2026 | 2 | GlobeNewswire (USA) | ||
| 09.04. | Stifel belässt Treace Medical auf 'Halten' mit Kursziel von 3 US-Dollar | 3 | Investing.com Deutsch |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PICARD MEDICAL | 4,460 | 0,00 % | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2026 Financial Results | - Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE... ► Artikel lesen | |
| GENEDX | 85,20 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| AVEANNA HEALTHCARE | 12,790 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROGYNY | 25,830 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 55,80 | 0,00 % | Here's What Lifted BrightSpring Health Services (BTSG) | ||
| LIFESTANCE HEALTH GROUP | 12,085 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,070 | -0,35 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| INNOVAGE | 9,000 | 0,00 % | InnovAge (INNV) Shares Tumble 9% After Hours: Here's Why | ||
| FRESENIUS | 45,400 | -1,82 % | Fresenius-Aktie: Score 4 - Der Patient in der Genesung - Warren Wise Podcast | Genesung ist noch keine Kerngesundheit. Fresenius meldet das beste Jahr seit Langem. Der Gewinn hat sich mehr als verdoppelt, die Schulden sind gesunken, und die Dividende ist zurück. Der Vorstand erklärt... ► Artikel lesen | |
| HEARTFLOW | 47,400 | +0,02 % | Canaccord raises HeartFlow stock price target on plaque analysis survey | ||
| ALIGNMENT HEALTHCARE | 7,840 | 0,00 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 19,100 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| ADAPTHEALTH | 5,700 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BETA BIONICS | 22,210 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| BILLIONTOONE | 114,47 | +0,04 % | Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently |
TREACE MEDICAL CONCEPTS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 4,510 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TREACE MEDICAL CONCEPTS INC finden Sie auf Wallstreet Online.